Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Digoxin therapy in chronic heart failure
Mihai Gheorghiade
*
*
Corresponding author for this work
Medicine, Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Digoxin therapy in chronic heart failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Digoxin
100%
Chronic Heart Failure
100%
Diuretics
37%
ACE Inhibitors
37%
Placebo
25%
Patients with Chronic Heart Failure
25%
Chronic Therapy
25%
Heart Failure
12%
Hospitalization
12%
Cardiac Function
12%
Hemodynamic Effects
12%
Placebo-controlled
12%
Daily Dose
12%
Clinical Evidence
12%
Drug Treatment
12%
Cardiac Output
12%
Worsening Heart Failure
12%
Serum Concentration
12%
Left Ventricular Systolic Function
12%
Acute Administration
12%
During Exercise
12%
Digitalis
12%
Central Hemodynamics
12%
Hemodynamic Deterioration
12%
Mortality Studies
12%
Radiance
12%
Randomized Withdrawal
12%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Digoxin
100%
Placebo
37%
Diuretic Agent
37%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Pharmacotherapy
12%
Deterioration
12%
Noradrenalin
12%